| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70571
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
2007-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22b343baae0aba7f14807d792f0aee47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_664a7ce3a3b458af956598d606799af3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a565a9393bb553fe1a6bc7cbb41b463d |
| publicationDate |
2009-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20090047532-A |
| titleOfInvention |
How to screen for compounds with anti-amyloid properties |
| abstract |
The present invention relates to a method for screening compounds having anti-amyloid properties. Methods for screening compounds with the ability to dissociate or interfere with high-affinity complexes between β-amyloid peptides and nicotine acetylcholine receptors in human cortical tissue are used for the therapeutic and / or prophylactic treatment of neurodegenerative diseases and especially Alzheimer's disease. It is possible to quickly identify the compound to be formed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11147816-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11701360-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018097628-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-038404-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10485802-B2 |
| priorityDate |
2006-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |